Your browser doesn't support javascript.
loading
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
Berg, Anna; Hoivik, Erling A; Mjøs, Siv; Holst, Frederik; Werner, Henrica M J; Tangen, Ingvild L; Taylor-Weiner, Amaro; Gibson, William J; Kusonmano, Kanthida; Wik, Elisabeth; Trovik, Jone; Halle, Mari K; Øyan, Anne M; Kalland, Karl-Henning; Cherniack, Andrew D; Beroukhim, Rameen; Stefansson, Ingunn; Mills, Gordon B; Krakstad, Camilla; Salvesen, Helga B.
Afiliación
  • Berg A; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Hoivik EA; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
  • Mjøs S; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Holst F; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
  • Werner HM; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Tangen IL; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
  • Taylor-Weiner A; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Gibson WJ; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
  • Kusonmano K; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Wik E; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
  • Trovik J; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Halle MK; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
  • Øyan AM; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
  • Kalland KH; Department of Cancer Biology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
  • Cherniack AD; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Beroukhim R; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
  • Stefansson I; Department of Cancer Biology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
  • Mills GB; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Krakstad C; Department of Clinical Science, Center for Cancer Biomarkers, University of Bergen, Norway.
  • Salvesen HB; Department of Gynecology and Obstetrics, Haukeland University Hospital, Norway.
Oncotarget ; 6(2): 1327-39, 2015 Jan 20.
Article en En | MEDLINE | ID: mdl-25415225

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Perfilación de la Expresión Génica / Proteómica / Obesidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Perfilación de la Expresión Génica / Proteómica / Obesidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos